FABP4 and colorectal carcinoma: In sex‐stratified analyses, higher FABP‐4 levels were associated with increased CRC‐specific (HR per SD = 1.16; 95% CI: 1.04–1.29) and all‐cause mortality (HR = 1.15; 95% CI: 1.04–1.28) among men, but not among women.